Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Standardized Tests Allowing the Evaluation of the Impacts of Glaucomatous Optic Neuropathy in Daily Life Activities

NCT05747781 is registered in ClinicalTrials.gov with Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts as lead sponsor.

NCT NCT05747781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05747781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Standardized Tests Allowing the Evaluation of the Impacts of Glaucomatous Optic Neuropathy in Daily Life Activities
Lead sponsor
Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Phase
Not applicable
Overall status
Not yet recruiting
Start date
March 1, 2023
Completion date
March 31, 2027
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

optic neuropathy